This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Join Syngene International at TIDES Digital Week 2020

Webinar: Challenges in Oligonucleotide Therapeutics (June 3 at 12pm EDT)

Oligonucleotide therapeutics is one of the most promising fields in modern medicine to treat several diseases of genetic and non-genetic nature, by modulating gene expression. Though advancement and growth in oligo therapeutics appear stable and promising, oligos face immense challenges for their use as therapeutics and these must be resolved before proceeding with regulatory approvals. Highly complex nature of oligo drugs requires novel and sophisticated process methods including new types of equipment that still satisfy the cGMP requirements. Successful application of these agents requires appropriate design and delivery strategies to increase their stability and intracellular uptake. Relatively inordinate cost of oligos is a major concern, arising from the less coupling efficiency and the excess use of amidites and thereby the high cost incurred in oligo process development. In this session, I will present the major challenges in oligo therapeutics, which are associated with technology, manufacturing, delivery and process of regulation.

Webinar Presented by:

Syngene International will also be at TIDES US in Boston, September 15-18

Stop by Booth #615

Register today using code SYNGENE for 10% off your conference pass